Immunoassay Market 2022
Market Research Future (MRFR) reports that the immunoassay in research and development (R&D) market could achieve a CAGR of 8.18% during the forecast period (2015-2023). The market’s value is anticipated to be around USD 475.3 million by 2023.
Growth Drivers and Key Barriers
Immunoassays find widespread use in several areas of pharmaceutical research, including disease diagnosis, therapeutic drug monitoring, bioequivalence studies, and clinical pharmacokinetics in drug discovery, among others. The boost in the incidence rate of chronic and infectious diseases, surge in research and development investment (R&D), and technological innovations could propel the market growth in the coming years.
Rising incidence rates of diseases, including thyroid problems, kidney problems, heart ailments, and adrenal gland tumors are poised to have a lucrative effect on the market. For instance, the Centers for Disease Control and Prevention reports that every year close to 7,35,000 Americans suffer from a heart attack. The primary reasons behind this could be the prevalence of sedentary lifestyle, bad eating habits and lack of physical activities.
Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/5841
Major Key Players:
Few of the leading players in the global immunoassay market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.p.A.
The global market for immunoassay in R&D has been segmented on the basis of type, application, and end user.
With respect to the type, the market is considered for Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Immunospot Assay (ELISpot), Radioimmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmunoassay, and Others.
Application-wise, the segments mentioned in the report are infectious diseases, cancer research, endocrinology, autoimmune diseases, and others.
The end-users covered by the report include pharmaceutical and biotechnology companies, academic institutions and laboratories, and others. Out of these, the pharmaceutical and biotechnology companies segment held the value of USD 174.3 million in 2017, which indicates its dominance in the market over other segments.
Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/immunoassay-market-5841
The global immunoassay market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On a regional basis, the Americas would showcase supremacy over other regions throughout the forecast period. This is attributed to headquartered major market participants, increasing expenditure on research and development activities, the rising burden of chronic diseases and sophisticated healthcare infrastructure, and growing adoption of immunoassay in the US and Canada. For instance, as per the data published by Pharmaceutical Research and Manufacturers of America (PhRMA), the US pharmaceutical research and development (R&D) expenditure had grown from USD 2 million in 1980 to USD 71.4 million in 2017.
Europe would follow Americas in terms of value over the forecast period due to flourishing pharmaceutical and biotechnology companies, mounting adoption in diagnostic measures, and growing use of chemiluminescent immunoassay in the UK, Germany, and France. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2016, Europe accounted for 21.5% of world pharmaceutical sales, which rose to 22.2% of global pharmaceutical sales in 2017.
Browse Related Reports @
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.